EFDID: 36596EFD: View Filing

Issuer: Genesis Biopharma, Inc (0001425205) - D

Accession: 0001144204-11-025734 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001425205
  • Entity Name:
    Genesis Biopharma, Inc
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Within 5 years (2007)
  • Address:
    11500 Olympic Boulevard
    Los Angeles, CA 90064
  • Persons:
    Related Persons 4
    Anthony Cataldo
    DirectorExecutive Officer
    Michael Handelman
    DirectorExecutive Officer
    Dr. L. Stephen Coles
    Director
    Dr. William Andrews
    Director
EDGAR: Offering Information
  • Accession Date:
    05/03/2011
  • First Sale Date:
    04/17/2011
  • Offering Amount:
    $1,000,000
  • Amount Sold:
    $500,000
  • Amount Remaining:
    $500,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Genesis Biopharma, Inc/s/ Michael HandelmanMichael HandelmanChief Financial Officer and Director2011-05-02